Literature DB >> 22231132

Alport syndrome: ACEIs delay RRT and increase lifespan in Alport syndrome.

Susan J Allison.   

Abstract

Entities:  

Year:  2012        PMID: 22231132     DOI: 10.1038/nrneph.2011.204

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  1 in total

1.  Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy.

Authors:  Oliver Gross; Christoph Licht; Hans J Anders; Bernd Hoppe; Bodo Beck; Burkhard Tönshoff; Britta Höcker; Simone Wygoda; Jochen H H Ehrich; Lars Pape; Martin Konrad; Wolfgang Rascher; Jörg Dötsch; Dirk E Müller-Wiefel; Peter Hoyer; Bertrand Knebelmann; Yves Pirson; Jean-Pierre Grunfeld; Patrick Niaudet; Pierre Cochat; Laurence Heidet; Said Lebbah; Roser Torra; Tim Friede; Katharina Lange; Gerhard A Müller; Manfred Weber
Journal:  Kidney Int       Date:  2011-12-14       Impact factor: 10.612

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.